These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6891873)

  • 21. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug treatment of hypertrophic cardiomyopathy].
    Hirzel HO
    Herz; 1985 Apr; 10(2):84-90. PubMed ID: 4039293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemodynamic effects of intravenous verapamil in patients with obstructive myocardiopathy].
    Picó-Aracil F; Ruipérez JA; García Alberola A; Molina E; Ruiz-Ros JA; Campos JV; García J; Jaén E
    Rev Esp Cardiol; 1988 Jan; 41(1):16-21. PubMed ID: 3353560
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
    Guo HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
    [No Abstract]   [Full Text] [Related]  

  • 25. Usefulness of Doppler echocardiography for determining hemodynamic improvement with intravenous verapamil in hypertrophic cardiomyopathy.
    Cooper M; Shaddy R; Silverman N; Enderlein M
    Am J Cardiol; 1985 Jul; 56(1):201-2. PubMed ID: 4040320
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypertrophic cardiomyopathy: an overview.
    Epstein SE; Maron BJ
    Clin Invest Med; 1980; 3(1-2):185-93. PubMed ID: 7008999
    [No Abstract]   [Full Text] [Related]  

  • 27. [Personal experience with the long-term administration of verapamil in hypertrophic cardiomyopathies].
    Gregor P; Widimský P; Cervenka V; Vísek V; Dvorák J; Sládková T
    Vnitr Lek; 1986 Dec; 32(12):1179-87. PubMed ID: 3824917
    [No Abstract]   [Full Text] [Related]  

  • 28. [The course of hypertrophic cardiomyopathy with outflow obstruction in patients under treatment].
    Cserhalmi L; Szabóki F; Csukás I; Ilovszky Z; Huszár G
    Orv Hetil; 1987 Aug; 128(35):1815-23. PubMed ID: 3627783
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemodynamic effects of medical and surgical therapy of hypertrophic obstructive cardiomyopathy (author's transl)].
    Lösse B; Kuhn H; Krönert H; Rafflenbeul D; Kirschner P; Schulte HD; Loogen F
    Z Kardiol; 1980 Jul; 69(7):470-7. PubMed ID: 7192456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
    [No Abstract]   [Full Text] [Related]  

  • 31. Idiopathic hypertrophic subaortic stenosis.
    Arbogast RC; White RS
    Am Fam Physician; 1981 Jul; 24(1):97-101. PubMed ID: 7196144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertrophic obstructive myocardiopathy (considerations on 2 cases)].
    Maiorescu M; Serafim N; Ciofu E; Stamate M; Cănănău S; Radu M
    Rev Pediatr Obstet Ginecol Pediatr; 1982; 31(4):319-28. PubMed ID: 6820559
    [No Abstract]   [Full Text] [Related]  

  • 33. The acute and chronic effects of pharmacological adrenergic blockade in obstructive cardiomyopathy.
    Bernstein L; Mitchell AS
    Isr J Med Sci; 1969; 5(4):803-5. PubMed ID: 5387789
    [No Abstract]   [Full Text] [Related]  

  • 34. [The comparative studies of hemodynamic effects of verapamil and propranolol in patients with acute myocardial infarction (author's transl)].
    Ichikawa M; Saito S; Takahashi N; Tomobe K; Yamamoto M; Watanabe I; Komaki K; Tanigawa N; Ozawa Y; Hatano M
    Kokyu To Junkan; 1979 Oct; 27(10):1103-7. PubMed ID: 504821
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy.
    Wilmshurst PT; Thompson DS; Juul SM; Jenkins BS; Webb-Peploe MM
    Br Heart J; 1986 Dec; 56(6):544-53. PubMed ID: 3801246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy.
    Spicer RL; Rocchini AP; Crowley DC; Vasiliades J; Rosenthal A
    Circulation; 1983 Feb; 67(2):413-20. PubMed ID: 6681534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute effects of nifedipine in hypertrophic cardiomyopathy. Echocardiographic and hemodynamic study].
    Terrosu P; Dore L; Sannia L; Piras L; Ibba GV
    Boll Soc Ital Cardiol; 1981; 26(12):1973-7. PubMed ID: 6892233
    [No Abstract]   [Full Text] [Related]  

  • 39. The natural history of hypertrophic cardiomyopathy.
    McKenna WJ; Goodwin JF
    Curr Probl Cardiol; 1981 Jul; 6(4):1-26. PubMed ID: 7026177
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy. A comparison of objective hemodynamic and exercise end points].
    Primo J; Tajik AJ
    Rev Port Cardiol; 1999 Nov; 18(11):1079-81. PubMed ID: 10608168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.